Major Developments in the Design of Inhibitors along the Kynurenine Pathway

Disrupted kynurenine pathway (KP) metabolism has been implicated in the progression of neurodegenerative disease, psychiatric disorders and cancer. Modulation of enzyme activity along this pathway may therefore offer potential new therapeutic strategies for these conditions. Considering their promin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Kelly R., Castellano-González, Gloria, Guillemin, Gilles J., Lovejoy, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748880/
https://www.ncbi.nlm.nih.gov/pubmed/28464785
http://dx.doi.org/10.2174/0929867324666170502123114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748880/
https://www.ncbi.nlm.nih.gov/pubmed/28464785
http://dx.doi.org/10.2174/0929867324666170502123114

Ejemplares similares